Human iPSC Line (Episomal, CB) was derived from human new born cord blood (CB) mononuclear cells by ectopic expression of OCT4, SOX2, KLF4, L-MYC and Lin28 genes using episomal plasmids. The cells were derived using morphological selection criteria and without the use of fluorescent marker or drug selection.
Request Your Custom Quote Today
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today to enhance your projects.
The human iPSC line (episomal, CB) is a type of human induced pluripotent stem cell (iPSC) that was derived from human newborn cord blood (CB) mononuclear cells. The cells were reprogrammed into an embryonic-like pluripotent state using a method involving the introduction of OCT4, SOX2, KLF4, L-MYC, and Lin28 genes through episomal plasmids. Cord blood cells are an attractive source of hematopoietic stem cells for transplantation, offering advantages such as easy and risk-free collection, minimal somatic mutations, and the immunological immaturity typically associated with newborn cells. Under standard human ES cell culture conditions, the morphology of these human iPSCs is indistinguishable from that of human embryonic stem cells (ES).
Why choose HighQC™ Human iPSC Line (Episomal, CB) from AcceGen?
The human iPSC line (episomal, CB) stands out with its high viability and adaptability to serum-free, feeder-free culture conditions. Each batch of iPSCs is meticulously tested, assessing their growth and viability. Our rigorous quality control measures ensure that the iPSC line is robust and suitable for a wide range of research applications.
Species
Human
Cat.No
ABC-SC003X
Quality Control
All cells test negative for mycoplasma, bacteria, yeast, and fungi.
Product Category
Primary Cells
Size/Quantity
1 vial
Cell Type
Induced Pluripotent Stem Cell
Shipping Info
Dry Ice
Growth Conditions
37 ℃, 5% CO2
Disease
Normal
Biosafety Level
1
Storage
Liquid Nitrogen
Product Type
Human iPSCs
Citation
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
View More
View Product Image
Application
FOR RESEARCH USE ONLY
The applications of human induced pluripotent stem cells (iPSCs), specifically the episomal cord blood (CB) iPSC line, are highly valuable in various research areas. iPSCs have significant potential in advancing cell therapy, particularly in the field of regenerative medicine. Researchers are particularly intrigued by the application of iPSC technology in modeling diseases. The ability to model diseases using iPSCs has proven to be a powerful tool for understanding and advancing treatment options. The human iPSC line (episomal, CB) holds great promise for accelerating progress in cell therapy development, regenerative medicine, and the study of blood diseases.
Online Inquiry
Product Reviews
Inquiring HighQC™ Human iPSC Line (Episomal, CB)
We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
